NCT03158389 2023-09-28
N²M²
University Hospital Heidelberg
Phase 1/2 Completed
Clinical Trials
3 trialsNCT01601184 2019-05-21
Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway
Centre Leon Berard
Phase 1/2 Terminated
NCT02690948 2019-03-08
Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer
Stanford University
Phase 1/2 Completed